通过SRT2104激活SIRT1,增强了线粒并减少了听觉细胞中的衰老
Sung Il Cho1, Eu-Ri Jo2,3, Hee Sun Jang2
1Department of Otolaryngology-Head and Neck Surgery, Chosun University College of Medicine, 365 Pilmun-daero, Dong-gu, Gwangju, Republic of Korea. chosi@chosun.ac.kr.
作为SIRT1激活剂的SRT2104,可以减少听觉细胞衰老,并增强线粒. 这种化合物通过增强线粒体功能和SIRT1活性来保护听力,为与年龄有关的听力损失提供了潜在的治疗方法.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 细胞生物学 细胞生物学
- 线粒体生物学 线粒体生物学
背景情况:
- 与年龄相关的听力损失涉及耳细胞退化,线粒体功能障碍和线粒体衰减.
- 赛尔图因1 (SIRT1) 调节线粒体质量控制和线粒体衰变.
- 目前尚不清楚SIRT1在听觉细胞衰老中的作用.
研究的目的:
- 研究SRT2104,SIRT1激活剂对听觉细胞中细胞衰老和线粒细胞衰变的影响.
- 为了确定SRT2104是否可以防止与年龄相关的听力损失机制.
主要方法:
- 通过使用过氧化 (H2O2) 来诱导HEI-OC1听觉细胞和耳扩展器的细胞衰老.
- SRT2104是作为预治疗进行的.
- 分析了与菌相关的关键蛋白质 (PINK1,帕金,BNIP3,LC3-II) 和衰老 (p53,p21).
- 评估了线粒体功能 (膜潜力,DNA完整性,ATP产生).
- 对SIRT1进行了敲击,以确认它的作用机制.
主要成果:
- SRT2104显著增加了SIRT1活性,并上调了线粒细胞衰变标志物.
- SRT2104降低了衰老标志物 (p53,p21) 和降低了β-银酸酶活性.
- 用SRT2104进行预治疗,可以保持线粒体的功能和完整性.
- 抑制SIRT1消除了SRT2104的保护作用,证实了SIRT1的依赖性.
结论:
- SRT2104有效地缓解过早衰老,并通过SIRT1激活促进听觉细胞中的线粒.
- 药理上激活SIRT1代表了与年龄相关的听力退化治疗的有希望的治疗策略.
更多相关视频
14:01Far-Red Fluorescent Senescence-Associated β-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry
Published on: September 13, 2022
07:04Author Spotlight: Assessment of Mitophagy Flux in Pancreatic β-Cells Using Effective and Robust Complementary Approaches
Published on: September 15, 2023
相关概念视频
Replicative Cell Senescence
The Auditory Ossicles
The aptly named stapes look very much like a stirrup. The three ossicles are unique to mammals, and each plays a role in...
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
Auditory Perception
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Self-Evaluation: Self-Enhancement and Self-Verification
